Wren Laboratories Limited

Wren Laboratories Limited, based in Andover, UK, is a sizable holding company with an active status, having been incorporated twenty-one years ago. The company employs eighty-five people and holds assets totaling £5,300,766. It has five directors and one owner, and its registered address is confirmed as real, with only one other company registered at the same location. Wren Laboratories regularly imports and exports miscellaneous food products, having imported for fourteen months and exported for forty-five months, with the latest activity occurring in January 2025.

The company's primary focus is on developing and providing mRNA diagnostics for cancer, operating as a Yale University spinoff and holding CLIA, CAP, and NYSDOH licenses. Wren Laboratories offers tests like NETest and PROSTest for neuroendocrine and prostate cancer, and actively collaborates with medical institutions worldwide. Its website highlights a commitment to innovation, patient-centric care, and global reach, with a focus on machine learning diagnostics and validated assays.

Financially, Wren Laboratories demonstrates a mixed picture. While cash bank on hand increased by 53% to £750,000, net assets significantly decreased by 62% to £1,200,000. The company’s turnover, however, declined by 62% to £240,000. Bank borrowings decreased by 86%, and creditors also decreased by 33%, suggesting improved debt management. Despite the decline in profits, the company’s assets remain substantial, and the decrease in liabilities is a positive sign. The company’s average number of employees increased by 20% to one hundred. The company’s auditor is Old Mill Audit Limited. The company is not meeting all criteria for a large company, with turnover under £36 million.

Registered in England/Wales under the registration number 05094520, with a registered address at SP11 8HU, England, Andover, Hampshire, 21 & 22 Mayfield Avenue Industrial Estate Fyfield Road, Weyhill.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.